-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Granules India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 12632.0
- ISIN : INE101D01020
-
Today’s Low
881.25 -
Today’s High
914.85
-
Open
895.95 -
Perv Close
899.25 -
52W Low
510.55 -
52W High
914.85
Key Indicators
-
P/E(TTM)
55.94
-
Mar.Cap (₹Cr.)
22,532.17
-
Div & Yield %
0.19
-
Book Value(₹)
162.77
-
Debt-Equity Ratio
1.12
-
AGM Date
11-Sep-2026
-
EPS
16.26
-
P/E Ratio
55.94
Financials Ratios
-
Debt-Equity Ratio
0.40
-
Mar.Cap (₹Cr.)
22,532.17
-
RONW (%)
13.38
-
ROCE (%)
15.22
Score Board
-
Equity (₹ in Cr.)
24.78
-
BV (₹)
162.80
-
Sales( ₹ in Cr.)
3,473.96
-
NP (in Cr.)
409.82
-
NP Var(%)
45.0
-
Div%
175.0
-
CPS (₹)
23.20
-
EPS (₹)
16.50
-
Traded Value (₹ in Lakhs)
22,540.85
-
52 Week High
914.85
-
52 Week Low
510.55
-
Price BSE
910.0
-
Price NSE
909.00
-
Market Capital( in Cr.)
22,540.85
-
P/C Ratio
39.30
-
P/E Ratio
55.00
-
Price Vs.BV
16.50
-
21-Jul-2026( 03:51)
Hot Pursuit - Granu... - <P> EBITDA improved by 37% to...
-
09-Jul-2026( 01:41)
Corporate News - Granu... - Granules India will hold a mee...
-
06-Jul-2026( 09:19)
Corporate News - Granu... - <P>Granules India announced th...
-
06-Jul-2026( 11:51)
Hot Pursuit - Granu... - <P> The aforementioned ANDA is...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 3,473.96 | 3,030.16 | 3,755.09 | 3,931.20 | 3,238.44 | 3,134.98 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,473.96 | 3,030.16 | 3,755.09 | 3,931.20 | 3,238.44 | 3,134.98 |
| Other Income | 49.80 | 71.43 | 5.78 | 9.93 | 17.51 | 13.72 |
| Stock Adjustments | -7.68 | 29.80 | 20.21 | -61.52 | 106.41 | -7.45 |
| Total Income | 3,516.08 | 3,131.39 | 3,781.08 | 3,879.61 | 3,362.36 | 3,141.25 |
| EXPENDITURE : | ||||||
| Raw Materials | 1,505.27 | 1,373.90 | 1,927.12 | 2,099.93 | 1,864.16 | 1,502.19 |
| Power and Fuel Cost | 100.19 | 90.31 | 93.01 | 88.95 | 69.91 | 65.51 |
| Employee Cost | 383.91 | 342.20 | 332.99 | 278.19 | 247.86 | 234.36 |
| Other Manufacturing Expenses | 162.29 | 145.65 | 142.30 | 117.40 | 121.37 | 110.80 |
| Selling and Administration Expenses | 555.47 | 510.21 | 428.83 | 420.15 | 364.58 | 320.46 |
| Miscellaneous Expenses | 47.23 | 32.90 | 49.69 | 26.82 | 32.31 | 32.83 |
| Employee Benefit Expenses | 383.91 | 342.20 | 332.99 | 278.19 | 247.86 | 234.36 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 2,754.36 | 2,495.16 | 2,973.93 | 3,031.44 | 2,700.20 | 2,266.16 |
| Operating Profit | 761.73 | 636.23 | 807.14 | 848.17 | 662.16 | 875.09 |
| Interest | 61.44 | 62.78 | 72.00 | 38.67 | 16.35 | 23.77 |
| Gross Profit | 700.29 | 573.45 | 735.14 | 809.50 | 645.81 | 851.32 |
| Depreciation | 164.47 | 146.23 | 143.85 | 145.56 | 126.16 | 118.45 |
| Profit Before Tax | 535.82 | 427.22 | 591.29 | 663.94 | 519.65 | 732.87 |
| Current Tax | 135.16 | 109.88 | 150.61 | 170.21 | 133.51 | 197.06 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -1.99 | 4.77 | -5.05 | -0.38 | -16.97 |
| Reported Net Profit | 400.67 | 319.34 | 435.92 | 498.79 | 386.52 | 552.78 |
| Extraordinary Items | -9.16 | 36.38 | -1.71 | -1.03 | -3.55 | -0.27 |
| Adjusted Net Profit | 409.83 | 282.96 | 437.63 | 499.82 | 390.07 | 553.05 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance brought forward | 2,891.24 | 2,608.26 | 2,208.65 | 1,728.49 | 1,379.14 | 851.10 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 36.40 | 36.35 | 36.31 | 18.62 | 37.17 | 24.75 |
| P & L Balance carried down | 3,255.51 | 2,891.24 | 2,608.26 | 2,208.65 | 1,728.49 | 1,379.14 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 175.00 | 150.00 | 150.00 | 150.00 | 150.00 | 150.00 |
| Dividend Per Share(Rs) | 1.75 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Earnings Per Share-Unit Curr | 16.17 | 13.17 | 17.99 | 20.61 | 15.58 | 22.32 |
| Earnings Per Share(Adj)-Unit Curr | 16.17 | 13.17 | 17.99 | 20.61 | 15.58 | 22.32 |
| Book Value | 162.77 | 140.31 | 128.36 | 111.53 | 102.04 | 87.32 |
| Book Value(Adj)-Unit Curr | 162.77 | 140.31 | 128.36 | 111.53 | 102.04 | 87.32 |
